Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects
暂无分享,去创建一个
W. Kraft | K. Yee | J. McCrea | D. Panebianco | Wen Liu | R. Wrishko | M. Chakravarthy | E. Mangin | Maria P. Martinez-Cantarin